federal_register: 06-9684
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| document_number | title | type | abstract | publication_date | pub_year | pub_month | html_url | pdf_url | agency_names | agency_ids | excerpts |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 06-9684 | Expanded Access to Investigational Drugs for Treatment Use | Proposed Rule | The Food and Drug Administration (FDA) is proposing to amend its regulations on access to investigational new drugs for the treatment of patients. The proposed rule would clarify existing regulations and add new types of expanded access for treatment use. Under the proposal, expanded access to investigational drugs for treatment use would be available to individual patients, including in emergencies; intermediate-size patient populations; and larger populations under a treatment protocol or treatment investigational new drug application (IND). The proposed rule is intended to improve access to investigational drugs for patients with serious or immediately life- threatening diseases or conditions, who lack other therapeutic options and who may benefit from such therapies. | 2006-12-14 | 2006 | 12 | https://www.federalregister.gov/documents/2006/12/14/06-9684/expanded-access-to-investigational-drugs-for-treatment-use | https://www.govinfo.gov/content/pkg/FR-2006-12-14/pdf/06-9684.pdf | Health and Human Services Department; Food and Drug Administration | 221,199 | The Food and Drug Administration (FDA) is proposing to amend its regulations on access to investigational new drugs for the treatment of patients. The proposed rule would clarify existing regulations and add new types of expanded access for treatment... |